Evidence map›Paper›PMID 23197815›Full record

ArticleStem cells translational medicine2012

Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential.

Igor Nazarov, Jae W Lee, Eric Soupene, Sara Etemad, Derrick Knapik, William Green, Elizaveta Bashkirova, Xiaohui Fang, Michael A Matthay, Frans A Kuypers and 1 more

Open access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. AnStem cell investigation · 2019
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Dehydrated human amnion/chorion membrane regulates stem cell activity in vitro.Journal of biomedical materials research. Part B, Applied biomaterials · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Igor NazarovChildren's Hospital Oakland Research Institute, Oakland, California 94609, USA.
Jae W Lee
Eric Soupene
Sara Etemad
Derrick Knapik
William Green
Elizaveta Bashkirova
Xiaohui Fang
Michael A Matthay
Frans A Kuypers
Vladimir B Serikov
University of California, San Francisco · US

Funding

SICKLE CELL SCHOLAR PLANU54HL070583 · NHLBI · CHILDREN'S HOSPITAL &RES CTR AT OAKLAND · PI VICHINKSY, ELLIOTT P. · 2003 to 2010
$12.0M
PREPARATION AND DISTRUBUTION OF ADULT STEM CELLS: HUMAN &RODENTP40RR017447 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI PROCKOP, DARWIN JOHNSON · 2003 to 2011
$8.9M
MECHANISMS OF ALVEOLAR EPITHELIAL FLUID CLEARANCER01HL051854 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHAY, MICHAEL A. · 1994 to 2012
$4.4M
Resolution of Clinical Lung InjuryR37HL051856 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHAY, MICHAEL A. · 2006 to 2015
$3.9M
RESOLUTION OF CLINICAL LUNG INJURYR01HL051856 · NHLBI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MATTHAY, MICHAEL A. · 1996 to 2005
$1.7M
Mesenchymal Stem Cells for Treatment of Acute Lung InjuryK08HL093026 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEE, JAE WOO · 2008 to 2012
$609k
Hematopoietic Stem Cells from Human Term PlacentaR43DK091963 · NIDDK · PLASALUS, LLC · PI VITERI, FERNANDO · 2011 to 2012
$490k
Stromal Stem Cells of Human Placenta for the Treatment of Acute Lung InjuryR43HL108327 · NHLBI · PLASALUS, LLC · PI VITERI, FERNANDO · 2012 to 2013
$361k
NCRR NIH HHS P40 RR017447NCRR NIH HHS P40RR017447NHLBI NIH HHS 1R43HL108327NHLBI NIH HHS HL-070583NHLBI NIH HHS HL-093026NHLBI NIH HHS HL-51854NHLBI NIH HHS HL-51856NHLBI NIH HHS K08 HL093026NHLBI NIH HHS R01 HL051854NHLBI NIH HHS R01 HL051856NHLBI NIH HHS R37 HL051856NHLBI NIH HHS R43 HL108327NHLBI NIH HHS U54 HL070583NIDDK NIH HHS 1R43DK091963NIDDK NIH HHS R43 DK091963
6 · The paper itself

Abstract

We describe human chorionic mesenchymal stem cell (hCMSC) lines obtained from the chorion of human term placenta with high therapeutic potential in human organ pathology. hCMSCs propagated for more than 100 doublings without a decrease in telomere length and with no telomerase activity. Cells were highly positive for the embryonic stem cell markers OCT-4, NANOG, SSEA-3, and TRA-1-60. In vitro, cells could be differentiated into neuron-like cells (ectoderm), adipocytes, osteoblasts, endothelial-like cells (mesoderm), and hepatocytes (endoderm)-derivatives of all three germ layers. hCMSCs effectively facilitated repair of injured epithelium as demonstrated in an ex vivo-perfused human lung preparation injured by Escherichia coli endotoxin and in in vitro human lung epithelial cultures. We conclude that the chorion of human term placenta is an abundant source of multipotent stem cells that are promising candidates for cell-based therapies.

Indexed as

Cell DifferentiationStem Cell TransplantationAnimalsBlotting, WesternCell LineageCell ProliferationChorionEctodermEndodermEnzyme-Linked Immunosorbent AssayFemaleHumansInfant, NewbornMaleMesenchymal Stem CellsMiceTelomeraseTERT protein, human

Identifiers

PMID23197815
PMCPMC3635148
OpenAlexW1993180216

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.